Deals
Explore the dynamic landscape of pharma deals, mergers, acquisitions, and partnerships. Stay informed about strategic collaborations, licensing agreements, and investments shaping the industry. Get insights into the business side of pharmaceuticals and discover the key players driving innovation and growth.
Eric Stonestreet, ‘Modern Family’ Actor, Joins Forces with Astellas’ Iveric Bio to Launch Vision Health Awareness Initiative
Iveric Bio, an Astellas-acquired biotech company, has initiated a compelling awareness campaign for a disease it recently gained FDA approval ...
Inventiva and Kezar partner with Asian biotechs to advance NASH and lupus drugs
In a strategic move, Inventiva and Kezar Life Sciences have successfully secured buyers for the Asian rights to their lead ...
Merck KGaA signs two deals with BenevolentAI and Exscientia to boost AI-driven drug discovery in oncology and immunology
Merck KGaA is making strategic moves in the field of AI-enabled drug discovery by entering into three-target partnerships with BenevolentAI ...
Genentech and PeptiDream expand peptide collaboration to explore radiopharmaceuticals for cancer
Japanese biotech firm PeptiDream continues to attract significant interest from major pharmaceutical companies. Genentech, a long-term partner, has entered into ...
Genentech and Orionis Biosciences team up to discover molecular glue drugs for oncology and neurodegeneration
Genentech, a subsidiary of Roche, is aggressively expanding its partnered portfolio into cutting-edge areas of research and development. Following a ...
Novo Nordisk partners with Aspen to boost insulin supply in Africa
Novo Nordisk, a prominent player in the diabetes pharmaceutical industry, is taking significant steps to bolster insulin supplies in Africa. ...
Pharmanovia buys 11 CNS drugs from Sanofi to expand its portfolio of repurposed medicines
Sanofi, in its ongoing effort to streamline its product portfolio, is divesting 11 central nervous system (CNS) medications to Pharmanovia, ...
Samsung Biologics expands antibody production deal with Bristol Myers Squibb for $242 million
Samsung Biologics, a leading biopharmaceutical contract manufacturing organization, has strengthened its partnership with Bristol Myers Squibb (BMS) by securing a ...
Mayo Clinic and GE Healthcare team up to advance theranostic imaging for cancer
The Mayo Clinic is strengthening its longstanding partnership with GE Healthcare by embarking on a series of new joint research ...
Cerba HealthCare buys Cirion Biopharma to boost bioanalytical services
French clinical trial lab and diagnostics provider Cerba HealthCare has acquired Canadian CRO Cirion Biopharma in a move aimed at ...
AbbVie drops option on Harpoon’s BCMA TriTAC for multiple myeloma
AbbVie has decided against pursuing its option on Harpoon Therapeutics’ anti-BCMA T-cell engager HPN217, thus avoiding a $200 million payment ...
First Wave acquires Sanofi’s Alzheimer’s drug for GI disorders, retains buyback option
First Wave BioPharma has seized an opportunity from Sanofi to revive a long-dormant molecule, capeserod, by paying an upfront sum ...
Calidi Biotherapeutics goes public through SPAC deal to advance off-the-shelf cancer treatments
Calidi Biotherapeutics, a San Diego-based biotech, has chosen the special purpose acquisition company (SPAC) path to enter the public market, ...
Phesi partners with Krystelis to boost diversity in clinical trials
Clinical research and analytics specialist Phesi, in collaboration with Krystelis, has introduced a groundbreaking service aimed at enhancing the diversity ...
U.S. government hires Icon to run trial of new COVID-19 vaccines
Icon, a prominent Contract Research Organization (CRO), has been chosen by the US Department of Health and Human Services’ Biomedical ...
Orchid Pharma to produce GSK and Shionogi’s antibiotic for global access
Orchid Pharma, a subsidiary of India’s Dhanuka Labs, has secured a sublicense to manufacture the antibiotic cefiderocol. This development is ...
Exelixis partners with AI company Insilico to discover new drugs, LIB sells China rights for PCSK9 drug
Exelixis, the pharmaceutical company recognized for its solid tumor medication Cabometyx, is adopting artificial intelligence (AI) to bolster its pipeline. ...
Vertex partners with Septerna to develop GPCR-targeting drugs for rare diseases
Septerna, a biotech company, has secured an additional $47.5 million in funding through a licensing agreement with Vertex, a prominent ...
Sandoz to market Samsung Bioepis’ biosimilar of Stelara in US and Canada
Sandoz is expanding its biosimilar portfolio by signing a commercialization agreement with Samsung Bioepis for a biosimilar version of Johnson ...
Moderna expands cancer vaccine portfolio with Immatics deal worth up to $1.7B
Moderna is intensifying its focus on cancer vaccines and cell therapies through a newly announced research partnership with Immatics, a ...
Nurix and Seagen Join Forces to Pioneer Cancer Therapies by Combining Protein Degradation and ADC Technologies
Seagen has just sealed a strategic partnership with Nurix Therapeutics, headquartered in San Francisco. This collaboration is poised to unlock ...
AstraZeneca and Verge partner to discover AI-driven drugs for rare neurodegenerative diseases
Verge Genomics is expanding its roster of Big Pharma partnerships by teaming up with AstraZeneca in a substantial $42 million ...
Asensus and Nvidia team up to boost AI-powered digital surgery solutions
Asensus Surgical, despite having secured approvals for its robotic and AI tools, is not resting on its laurels. The company ...
Otsuka and Shape Therapeutics join forces to create gene therapies for eye diseases using AI-powered platform
Just a week after Otsuka Pharmaceutical ventured into the psychedelics sector, the Japanese pharmaceutical giant has struck a collaboration deal ...
Permira Buys Out CRO Ergomed For £703 Million In Private Deal
Permira, the London-based private equity firm, has made a substantial investment of 703 million pounds sterling (equivalent to $886 million) ...
Singapore’s Hiro Acquires US Oncology CRO To Expand Its Global Footprint
Singapore-based Harvest Integrated Research Organization, known as HiRO, is making a significant move to bolster its global presence through the ...
Novo Nordisk Renews Partnership With Harvard And Broad Institute To Discover New Diabetes And Heart Disease Drugs
Novo Nordisk has announced a collaborative effort with Harvard University and the Broad Institute of MIT to embark on a ...
Royalty Pharma Pays $150M To Ascendis For A Share Of Skytrofa Sales
Royalty Pharma, renowned for its investments in exchange for long-term drug royalties, has entered into a collaboration with Ascendis Pharma ...
Abbott Partners With Bigfoot Biomedical To Integrate Diabetes Devices
Abbott has made a significant move by acquiring Bigfoot Biomedical, a diabetes management technology maker. While the financial terms of ...
Nestlé abandons $2 billion peanut allergy drug Palforzia after disappointing sales and safety issues
Nestlé has completed the sale of its peanut allergy drug, Palforzia, to the U.S.-based allergy specialist Stallergenes Greer for an ...
